United Capital Financial Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$45.3M Buy
522,544
+17,509
+3% +$1.68M 0.28% 71
2025
Q4
$48.5M Buy
505,035
+6,095
+1% +$592K 0.29% 69
2025
Q3
$47.5M Buy
498,940
+7,725
+2% +$710K 0.34% 63
2025
Q2
$42.8M Buy
491,215
+20,434
+4% +$1.73M 0.35% 64
2025
Q1
$42.3M Buy
470,781
+6,345
+1% +$568K 0.36% 57
2024
Q4
$37.1M Buy
464,436
+77,010
+20% +$6.67M 0.31% 71
2024
Q3
$34.9M Sell
387,426
-7,914
-2% -$666K 0.29% 76
2024
Q2
$31.1M Sell
395,340
-42,065
-10% -$3.45M 0.27% 77
2024
Q1
$38.1M Sell
437,405
-11,657
-3% -$995K 0.31% 70
2023
Q4
$37M Sell
449,062
-216,975
-33% -$16.5M 0.31% 73
2023
Q3
$52.2M Sell
666,037
-69,274
-9% -$5.8M 0.34% 65
2023
Q2
$64.8M Sell
735,311
-2,539
-0.3% -$219K 0.35% 54
2023
Q1
$59.5M Sell
737,850
-638,362
-46% -$52M 0.33% 62
2022
Q4
$107M Buy
1,376,212
+715,755
+108% +$58M 0.6% 33
2022
Q3
$53.3M Buy
660,457
+8,649
+1% +$777K 0.32% 68
2022
Q2
$58.5M Buy
651,808
+20,496
+3% +$2.08M 0.32% 70
2022
Q1
$70M Buy
631,312
+27,887
+5% +$2.95M 0.34% 60
2021
Q4
$62.4M Buy
603,425
+9,154
+2% +$1.06M 0.29% 68
2021
Q3
$74.5M Sell
594,271
-4,433
-0.7% -$574K 0.37% 54
2021
Q2
$74.3M Buy
598,704
+15,103
+3% +$1.9M 0.37% 54
2021
Q1
$68.9M Buy
583,601
+3,574
+0.6% +$419K 0.38% 54
2020
Q4
$67.9M Sell
580,027
-45,713
-7% -$5.03M 0.41% 48
2020
Q3
$65M Buy
625,740
+51,205
+9% +$5.14M 0.42% 48
2020
Q2
$52.7M Buy
574,535
+18,858
+3% +$1.81M 0.38% 59
2020
Q1
$50.1M Sell
555,677
-16,164
-3% -$1.72M 0.41% 54
2019
Q4
$64.9M Buy
571,841
+11,396
+2% +$1.25M 0.42% 43
2019
Q3
$60.9M Sell
560,445
-50,045
-8% -$5.22M 0.43% 43
2019
Q2
$59.5M Buy
610,490
+16,094
+3% +$1.47M 0.39% 52
2019
Q1
$54.1M Buy
594,396
+1,411
+0.2% +$126K 0.38% 53
2018
Q4
$53.9M Buy
592,985
+5,405
+0.9% +$505K 0.43% 48
2018
Q3
$57.8M Buy
587,580
+54,215
+10% +$5.01M 0.41% 54
2018
Q2
$45.7M Sell
533,365
-3,016
-0.6% -$252K 0.34% 57
2018
Q1
$43M Buy
536,381
+185,593
+53% +$15.3M 0.33% 66
2017
Q4
$28.5M Buy
350,788
+11,098
+3% +$889K 0.23% 102
2017
Q3
$26.4M Buy
339,690
+8,410
+3% +$698K 0.22% 105
2017
Q2
$29.4M Buy
331,280
+4,409
+1% +$372K 0.26% 89
2017
Q1
$26.3M Buy
326,871
+142,766
+78% +$11.2M 0.25% 95
2016
Q4
$13.1M Sell
184,105
-28,759
-14% -$2.26M 0.13% 185
2016
Q3
$18.4M Buy
212,864
+30,700
+17% +$2.68M 0.18% 134
2016
Q2
$15.8M Sell
182,164
-15,565
-8% -$1.26M 0.16% 145
2016
Q1
$14.8M Buy
197,729
+1,036
+0.5% +$78K 0.16% 132
2015
Q4
$15.1M Sell
196,693
-9,614
-5% -$724K 0.17% 125
2015
Q3
$13.8M Buy
206,307
+11,890
+6% +$876K 0.17% 127
2015
Q2
$14.4M Sell
194,417
-11,651
-6% -$890K 0.17% 138
2015
Q1
$15.3M Buy
206,068
+94,249
+84% +$7.14M 0.19% 124
2014
Q4
$8.07M Buy
111,819
+42,570
+61% +$2.96M 0.12% 195
2014
Q3
$4.29M Buy
69,249
+1,509
+2% +$95.9K 0.07% 279
2014
Q2
$4.32M Buy
67,740
+12,263
+22% +$745K 0.08% 256
2014
Q1
$3.41M Buy
55,477
+1,595
+3% +$92.9K 0.07% 267
2013
Q4
$3.09M Buy
53,882
+41,306
+328% +$2.34M 0.11% 188
2013
Q3
$670K Sell
12,576
-72,376
-85% -$3.89M 0.02% 399
2013
Q2
$4.37M Buy
+84,952
New +$4.2M 0.12% 212

Other funds holding MDT

United Capital Financial Advisors's MDT Position: Q1 2026 in Review

United Capital Financial Advisors increased its Medtronic (MDT) stake by 3.5% in Q1 2026, buying an estimated $1.68M and bringing the position to 522,544 shares worth $45.3M. The position accounts for 0.28% of the portfolio, ranked #71.

United Capital Financial Advisors first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $107M in Q4 2022. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • United Capital Financial Advisors held 522,544 shares of Medtronic worth $45.3M as of Q1 2026.
  • United Capital Financial Advisors bought 17,509 Medtronic shares in Q1 2026, an estimated $1.68M.
  • Medtronic made up 0.28% of United Capital Financial Advisors's portfolio in Q1 2026, its #71 holding.
  • United Capital Financial Advisors first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • United Capital Financial Advisors's Medtronic position peaked at $107M in Q4 2022.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on United Capital Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.